Rock Springs Capital Management’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-55,861
Closed -$10.2M 116
2024
Q3
$10.2M Sell
55,861
-49,708
-47% -$9.05M 0.33% 69
2024
Q2
$19.4M Buy
105,569
+1,600
+2% +$294K 0.58% 53
2024
Q1
$18.5M Hold
103,969
0.47% 61
2023
Q4
$12.9M Buy
103,969
+13,409
+15% +$1.66M 0.32% 67
2023
Q3
$10.5M Buy
90,560
+55,659
+159% +$6.46M 0.28% 72
2023
Q2
$4.1M Buy
+34,901
New +$4.1M 0.1% 90